More importantly, YTHDF1, IGF2BP3 and NKAP were also highly expressed in pan-cancer, which provided the promise of YTHDF1, IGF2BP3 and NKAP as potential therapeutic targets. The gene discussed is IGF2BP3; the disease is cancer.